EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

EPHX1 and ERCC2 polymorphisms are associated with cisplatin-induced nephrotoxicity and prognosis in Thai cancer patients

Saad Ahmed, Jakris Eu-Ahsunthornwattana iD, Thanaporn Thamrongjirapat, Aruchalean Taweewongsounton, Yutthana Rittavee, Nintita Sripaiboonkit Thokanit iD, Montien Ngodngamthaweesuk, Pitichote Hiranyatheb, Thanyanan Reungwetwattana, Nuttapong Ngamphaiboon, Natini Jinawath iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0324699 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Saad Ahmed und 10 weiteren Autor:innen. Beteiligte Einrichtung: Program in Translational Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Xeroderma Pigmentosum Group D Protein, Cisplatin, Polymorphism, Single Nucleotide, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mahidol University, National Science Research and Innovation, Faculty of Medicine Ramathibodi hospital, Mahidol University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin is a widely used chemotherapeutic drug for various cancers. One of the common adverse effects of cisplatin is nephrotoxicity including acute kidney injury (AKI) and acute kidney disease (AKD). Single Nucleotide Polymorphisms (SNPs) can be used to identify cancer patients who are susceptible to developing cisplatin-induced nephrotoxicity (CIN). In this study, we validated the association between 6 SNPs in the drug metabolizing enzyme genes, SLC22A2 (rs316019) & EPHX1 (rs1051740), and the DNA repair genes, ERCC1 (rs11615 & rs3212986) & ERCC2 (rs13181 & rs1799793), and CIN in the 169 Thai patients with head and neck, lung, or esophageal cancer. Effect of these SNPs on cumulative incidence of AKD, progression-free survival (PFS), and overall survival (OS) was also assessed. EPHX1 rs1051740 TC genotype was significantly associated with AKD in co-dominant [OR 2.894, 95% CI 1.091–7.680; P = 0.033] and over-dominant [OR 2.793, 95% CI 1.333–5.851; P = 0.006] models, and with an increased cumulative incidence of AKD ( P = 0.021). Additionally, ERCC2 rs13181 and rs1799793 were significantly associated with OS ( P = 0.002 and 0.004). Our results reveal an association between EPHX1 rs1051740 and AKD, and confirms the previously reported associations between ERCC2 SNPs and OS. These findings may help in predicting CIN in Thai cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Xeroderma Pigmentosum Group D ProteinCisplatinPolymorphism, Single NucleotideAntineoplastic AgentsAcute Kidney InjuryNeoplasmsHumansMaleFemaleMiddle AgedThailandPrognosisAgedOrganic Cation Transporter 2DNA-Binding ProteinsAdultEndonucleasesGenotypeGenetic Predisposition to DiseaseSoutheast Asian PeopleEpoxide Hydrolases

Substanzen

Xeroderma Pigmentosum Group D ProteinERCC2 protein, humanCisplatinEPHX1 protein, humanAntineoplastic AgentsOrganic Cation Transporter 2DNA-Binding ProteinsSLC22A2 protein, humanEndonucleasesERCC1 protein, human

Autor:innen und Institutionen

  • Program in Translational Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Department of Community Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Division of Medical Genetics and Molecular Medicine, Department of Internal Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Division of Medical Oncology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Research Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bang Phli, Samut Prakarn, Thailand.

ORCID-Profile: Jakris Eu-Ahsunthornwattana, Nintita Sripaiboonkit Thokanit, Natini Jinawath

Förderung

  • Mahidol University
  • National Science Research and Innovation
  • Faculty of Medicine Ramathibodi hospital, Mahidol University
  • Scholarships for Ph.D. Students from Mahidol University

Zitieren

APA

Ahmed, S., Eu-Ahsunthornwattana, J., Thamrongjirapat, T., Taweewongsounton, A., Rittavee, Y., Thokanit, N. S., Ngodngamthaweesuk, M., Hiranyatheb, P., Reungwetwattana, T., Ngamphaiboon, N., & Jinawath, N. (2025). EPHX1 and ERCC2 polymorphisms are associated with cisplatin-induced nephrotoxicity and prognosis in Thai cancer patients. PLOS One. https://doi.org/10.1371/journal.pone.0324699

Vancouver

Ahmed S, Eu-Ahsunthornwattana J, Thamrongjirapat T, Taweewongsounton A, Rittavee Y, Thokanit NS, et al. EPHX1 and ERCC2 polymorphisms are associated with cisplatin-induced nephrotoxicity and prognosis in Thai cancer patients. PLOS One. 2025. doi:10.1371/journal.pone.0324699

BibTeX
@article{Ahmed2025,
  author = {Ahmed, Saad and Eu-Ahsunthornwattana, Jakris and Thamrongjirapat, Thanaporn and Taweewongsounton, Aruchalean and Rittavee, Yutthana and Thokanit, Nintita Sripaiboonkit and Ngodngamthaweesuk, Montien and Hiranyatheb, Pitichote and Reungwetwattana, Thanyanan and Ngamphaiboon, Nuttapong and Jinawath, Natini},
  title = {EPHX1 and ERCC2 polymorphisms are associated with cisplatin-induced nephrotoxicity and prognosis in Thai cancer patients},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0324699}
}
Kostenlos starten →